Compare HCA Health Inc (HCA) vs Somnigroup International Inc. Common Stock (SGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Somnigroup International Inc. Common Stock — how do they compare? HCA Health Inc trades at $475.56 (market cap $101.85B), while Somnigroup International Inc. Common Stock trades at $62.87 (market cap $14.28B). The key difference: HCA Health Inc is far larger — about 7.1× Somnigroup International Inc. Common Stock's market cap, and Somnigroup International Inc. Common Stock pays the higher dividend (1.1%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Somnigroup International Inc. Common Stock for 0 Days on average.
| HCA | SGI | |
|---|---|---|
Market Cap | $101.85B | $14.28B |
Volume | 1,081,388 | 2,254,312 |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $97.99 |
52-Week Low | $361.32 | $61.49 |
Typical Hold Time | 76 Days | 0 Days |
Enterprise Value | $152.39B | $20.58B |
Dividend Yield | 0.66% | 1.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $460.75, up 0.47% today, with a bullish technical outlook and strong fundamental performance. The stock shows consistent earnings beats, with Q2 2026 EPS of $7.59 exceeding expectations. Revenue grew to $75.60 billion in 2025, and net income reached $6.78 billion. Analyst consensus is bullish, with a $461.12 price target. Recent news includes an upcoming Q3 2026 earnings call and ongoing legal investigations.
Outlook remains positive due to solid demand and cost controls, but risks include regulatory scrutiny and debt levels. The stock offers growth potential from operational efficiency, though investors should monitor legal developments and payer-mix pressures. Valuation metrics like a P/E of 15.45 suggest reasonable pricing relative to earnings.
Somnigroup International (SGI) trades at $62.87, up 0.75% with neutral technical signals. The company shows strong profitability with 44.24% gross margins and has beaten earnings estimates for three consecutive quarters. Recent acquisition of Leggett & Platt enhances vertical integration with $75M synergy target. Analyst consensus is strongly bullish with 91% buy ratings and $94.50 price target, representing 50% upside potential from current levels.
SGI presents compelling growth prospects through strategic acquisitions and operational efficiencies, though faces margin pressures in weak bedding markets. The stock trades at reasonable valuations (P/E 24.85) with improving cash flow trends expected in 2026. Key risks include integration execution and market competition, but strong institutional interest and insider buying support the bullish case.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Somnigroup International Inc. Common Stock
Somnigroup International Inc. (formerly Tempur Sealy International) is a bedding and sleep-products company that designs, manufactures, distributes, and retails mattresses and related products. It operates through Tempur Sealy North America, Tempur Sealy International, and Mattress Firm, with brands including Tempur-Pedic, Sealy, Stearns & Foster, and Mattress Firm.
Read more on SGI →
